An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants
Clinical trial NCT00591565 · COMPLETED
Trial details
- NCT number
- NCT00591565
- Sponsor
- State University of New York - Upstate Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.